Cough as Noninvasive Biomarker for Monitoring Tuberculosis Treatment: A Proof-of-Concept Study
Ann Am Thorac Soc
.
2023 Dec;20(12):1822-1825.
doi: 10.1513/AnnalsATS.202305-456RL.
Authors
Saskia Janssen
1
,
Caryn M Upton
1
,
Veronique R De Jager
1
,
Alan Faraj
2
,
Madhurananda Pahar
3
,
Igor D S Miranda
4
,
Andreas H Diacon
1
,
Ulrika S H Simonsson
2
,
Thomas R Niesler
3
Affiliations
1
TASK Cape Town, South Africa.
2
Uppsala University Uppsala, Sweden.
3
Stellenbosch University Stellenbosch, South Africa.
4
Federal University of Recôncavo da Bahia Bahia, Brazil.
PMID:
37751498
DOI:
10.1513/AnnalsATS.202305-456RL
No abstract available
Publication types
Letter
MeSH terms
Antitubercular Agents / therapeutic use
Biomarkers
Cough* / etiology
Humans
Tuberculosis* / drug therapy
Substances
Antitubercular Agents
Biomarkers